Skip to main content

Catholic Health Cancer Clinical Trials

The Future of Cancer Therapy

Catholic Health is strengthening its commitment to providing outstanding cancer care for Long Islanders by becoming a member of Roswell Park Care Network. Based in upstate New York, Roswell Park has long enjoyed a sterling reputation as one of the nation's premier cancer centers.

Now it is partnering with physicians, hospitals and supportive care teams across the state to create an expansive community-based care network dedicated to easing the burden of cancer. This network provides increased access to clinical trials—some of which are only available at Roswell Park.

Through its affiliation with Roswell Park, Catholic Health has the opportunity to provide cancer patients with some of the newest and most innovative treatments available only through clinical trials.

Call 844-86-CANCER (844-862-2623) or submit a form for more information.

The Future of Cancer Care at Roswell Park (Video courtesy of Roswell Park Comprehensive Care Center)

Learn more about Roswell Park (Video courtesy of Roswell Park Comprehensive Care Center)

Find a Catholic Health Cancer Institute near you

Why Clinical Trials?

Image
Scientist with mircroscope

A clinical trial is a type of clinical research study that tests the safety and effectiveness of new medical approaches. Some clinical trials test a drug, a medical device or a new way of doing surgery. Other trials test new ways to prevent disease, diagnose cancer or improve quality of life. Clinical trials play an essential role in the fight against cancer. They are the only scientific way to prove whether a new treatment works better than the current standard of care. (Source: Roswell Park)

Learn more to help you decide about participation in a clinical trial

What You Need to Know About Clinical Trials

Current Open Clinical Trials

Breast Cancer

What is breast cancer?

Breast cancer risk factors

Breast cancer symptoms in women

  • A phase lll Double-blind randomized study assessing the efficacy of capivasertib + paclitaxel versus placebo + paclitaxel as first-line treatment for patients with histologically confirmed locally advanced or metastatic triple-negative breast cancer (TNBC)
  • ARM: Axillary Reverse Mapping - A Prospective Trial to Study Rates of Lymphedema and Regional Recurrence after Sentinel Lymph Node Biopsy and Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Dissection with and without Axillary Reverse Mapping

Chronic Lymphocytic Leukemia

What is CLL?

CLL risk factors and symptoms

  • Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (= 70 Years of Age) with Chronic Lymphocytic Leukemia

Colon Cancer

What is colon cancer?

Colon cancer risk factors

Colon cancer symptoms

  • Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch

Head & Neck

What are cancers of the head & neck?

Risk factors and prevention

Signs and symptoms

  • A phase I/II Basket Trial of the EGF Vaccine CIMAvax in combination with the Anti-PD1 therapy in patients with advanced NSCLC or squamous head and neck cancer.

Lung Cancer

What is lung cancer?

Lung cancer risk factors

Lung cancer symptoms 

  • A phase I/II Basket Trial of the EGF Vaccine CIMAvax in combination with the Anti-PD1 therapy in patients with advanced NSCLC or squamous head and neck cancer.
  • Randomized Phase III Study of Combination AZD9291 (osimertinib) and Bevacizumab versus AZD9291 (osimertinib) Alone as First-Line Treatment for Patients with Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

Metastatic Disease

  • ASTEROID- Assessing Single-Fraction SBRT versus Standard Palliative Radiation in Patients with Metastatic Disease

Multiple Myeloma

What is multiple myeloma?

Watch: Signs and Symptoms of Myeloma (Courtesy of Roswell Park Comprehensive Care Center)

  • Phase II Study of Targeting CD28 in Multiple Myeloma with Abatacept to Overcome Resistance to Chemotherapy
    • Principal Investigators: Dr. Dilip Patel, Dr. Sudha Mukhi
    • Summary: This Phase II trial studies how well abatacept, ixazomib citrate, and dexamethasone work in treating patients with multiple myeloma that is resistant to chemotherapy. Abatacept may block certain proteins that are present on multiple myeloma cells that have been shown to protect against chemotherapy. Drugs used in chemotherapy, such as ixazomib citrate and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving abatacept, ixazomib citrate, and dexamethasone may work better at treating patients with multiple myeloma resistant to chemotherapy.
    • Read more about the study

Other

  • Cadence Registry Sanofi CADENCE Registry - Cold Agglutinin Disease Real World Evidence Registry 
    • Principal Investigator: Dr. George Zervos
  • St. Francis Hospital Cardio-Oncology Registry 
    • Principal Investigator: Dr. Haoyi Zheng
  • The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry
    • Principal Investigator: Dr. Dilip Patel
Share


Contact Us